Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idera Pharmaceuticals Inc

+ Add to Watchlist

IDRA:US

4.6300 USD 0.2100 4.34%

As of 20:10:00 ET on 03/03/2015.

Company Profile for Idera Pharmaceuticals Inc (IDRA)

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Contact Information

Idera Pharmaceuticals Inc

167 Sidney Street
Cambridge, MA 02139
United States
Phone: 1-617-679-5500
Fax: 1-617-679-5592

Key Executives for Idera Pharmaceuticals Inc (IDRA)

Vincent J Milano "Vin"President/CEOSudhir D Agrawal "Phil"President:Research
Louis J Arcudi IIISenior VP/CFO/Treasurer/SecyLouis BrennerSenior VP/Chief Medical Ofcr
J Peter Wolf "Pete"Senior VP/General CounselRobert C FletcherSenior VP:Bus Dev & Strategic Planning
Nancy WyantVP:Clinical OperationsTimothy M SullivanVP:Dev Programs & Alliance
Kathryn HavilandVP:Rare DiseasesElizabeth Eberhardt "Liz"VP:Oncology
Robert A Doody Jr "Bob"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil